Repligen
RGEN
#2549
Rank
$6.63 B
Marketcap
$117.82
Share price
5.68%
Change (1 day)
-7.40%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of December 2025 : $2.94 Billion USD

According to Repligen 's latest financial reports the company's total assets are $2.94 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31$2.94 B4.24%
2024-12-31$2.82 B-0.05%
2023-12-31$2.83 B11.83%
2022-12-31$2.53 B7.35%
2021-12-31$2.35 B23.94%
2020-12-31$1.90 B35.91%
2019-12-31$1.40 B80.75%
2018-12-31$0.77 B4.18%
2017-12-31$0.74 B157.35%
2016-12-31$0.28 B97.56%
2015-12-31$0.14 B13.99%
2014-12-31$0.12 B8.13%
2013-12-31$0.11 B22.3%
2012-12-31$97.01 M
2011-03-31$72.29 M1.22%
2010-03-31$71.41 M-3.17%
2009-03-31$73.75 M7.14%
2008-03-31$68.83 M136.76%
2007-03-31$29.07 M1.67%
2006-03-31$28.59 M3.59%
2005-03-31$27.6 M-6.78%
2004-03-31$29.61 M10.53%
2003-03-31$26.79 M-7.96%
2002-03-31$29.11 M-9.45%
2001-03-31$32.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
$208.16 B 6,956.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$110.34 B 3,640.82%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$130.16 B 4,312.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$90.03 B 2,952.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$88.64 M-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.17 B-60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$4.63 B 57.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$2.52 B-14.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$7.59 B 157.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$7.13 B 141.90%๐Ÿ‡บ๐Ÿ‡ธ USA